Genital Diseases, Female News

Genital Diseases, Female	Welcome, Profile Billing Logout

«1 2...33 34 35 36 373839 40 41 42 43...110 111 »

|||||||||| Trial completion, Preclinical: Management of Abnormally Fertilized Zygotes? InVitro Correction of 3PN (clinicaltrials.gov) - Jan 15, 2016
P0, N=22, Completed, Sponsor: Ahmad Mustafa Mohamed Metwalley
Enrolling by invitation --> Completed

||||||||||  clomifene citrate / Generic mfg.
New P2 trial:  Correction of Vitamin D Deficiency and Its Effect on Ovulation Induction in Women With PCOS (VIDEO): A Feasibility RCT (clinicaltrials.gov) -  Jan 14, 2016
P2, N=210, Not yet recruiting,  Sponsor: Ain Shams University

||||||||||  letrozole / Generic mfg.
Trial completion:  Outcome of Three Controlled Ovarian Hyperstimulation Protocols in Poor Responding Infertility Patients (clinicaltrials.gov) -  Jan 12, 2016
P=N/A, N=95, Completed,  Sponsor: Istanbul University
Enrolling by invitation --> Completed Active, not recruiting --> Completed

|||||||||| Phase classification: Flaxseed Lignan (Brevail) (clinicaltrials.gov) - Jan 11, 2016
P0, N=9, Completed, Sponsor: University of Kansas Medical Center
Active, not recruiting --> Completed Phase classification: P=N/A --> P0

||||||||||  ethinyl estradiol/levonorgestrel / Generic mfg., naproxen / Generic mfg.
Trial completion, Enrollment change, HEOR:  iTOM: Medical Therapy Versus Radiofrequency Endometrial Ablation in the Initial Treatment of Menorrhagia (clinicaltrials.gov) -  Jan 11, 2016
P4, N=67, Completed,  Sponsor: Abimbola Famuyide
Phase classification: P=N/A --> P0 Active, not recruiting --> Completed | N=120 --> 67

|||||||||| New trial: Endometriosis and Brominated Flame Retardant (ENDOTOX Study) (clinicaltrials.gov) - Jan 11, 2016
P=N/A, N=76, Completed, Sponsor: Nantes University Hospital

|||||||||| New trial, Preclinical: Does in Vivo Culture of Pre-cleavage Stage Embryo Reduce the Incidence of Aneuploidy? (clinicaltrials.gov) - Jan 11, 2016
P=N/A, N=35, Recruiting, Sponsor: Anecova SA

|||||||||| New trial: Combined Therapy With Myo-inositol and Alpha-Lipoic Acid in PCOS Women (clinicaltrials.gov) - Jan 11, 2016
P=N/A, N=40, Completed, Sponsor: Catholic University of the Sacred Heart

||||||||||  Orgalutran (ganirelix acetate) / Organon, Follistim AQ Cartridge (follitropin beta) / Organon, Elonva (corifollitropin alfa) / Organon
Trial completion, Preclinical, Enrollment change, Trial primary completion date:  Ovarian Response Prediction in In Vitro Fertilization (IVF) Patients (clinicaltrials.gov) -  Jan 7, 2016
P=N/A, N=294, Completed,  Sponsor: University of Schleswig-Holstein
Active, not recruiting --> Completed | N=120 --> 67 Recruiting --> Completed | N=240 --> 294 | Trial primary completion date: Jul 2013 --> Dec 2013

|||||||||| Trial completion, Enrollment change: WOMAN-PROII: The Impact of the "WOMAN-PRO II Program" on Patients With Vulvar Neoplasia to Minimize Post-surgical Symptom Prevalence (clinicaltrials.gov) - Jan 7, 2016
P2, N=45, Completed, Sponsor: St.Gallen University of Applied Sciences
Recruiting --> Completed | N=240 --> 294 | Trial primary completion date: Jul 2013 --> Dec 2013 Recruiting --> Completed | N=90 --> 45

|||||||||| Trial completion: Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine (clinicaltrials.gov) - Jan 7, 2016
P2, N=1600, Completed, Sponsor: Xiamen University
Recruiting --> Completed | N=90 --> 45 Active, not recruiting --> Completed

|||||||||| Trial completion: A Randomized Online Health Experiment for a Safer Youth Sexual Behaviour (clinicaltrials.gov) - Jan 5, 2016
P=N/A, N=996, Completed, Sponsor: University Hospital of North Norway
Active, not recruiting --> Completed Recruiting --> Completed

||||||||||  metformin / Generic mfg.
Enrollment open:  Effect of Metformin on Early Pregnancy Loss in Pregnant Women With Polycystic Ovarian Syndrome (clinicaltrials.gov) -  Dec 31, 2015
P0, N=166, Recruiting,  Sponsor: Ain Shams University
Recruiting --> Completed Not yet recruiting --> Recruiting

|||||||||| Enrollment closed: A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (clinicaltrials.gov) - Dec 31, 2015
P3, N=979, Active, not recruiting, Sponsor: Jun Zhang
Not yet recruiting --> Recruiting Not yet recruiting --> Active, not recruiting

|||||||||| Trial primary completion date: The Use of Levonorgestrel-Releasing Device (Metraplant-E) in the Treatment of Dysfunctional Uterine Bleeding (clinicaltrials.gov) - Dec 30, 2015
P3, N=50, Recruiting, Sponsor: Ain Shams Maternity Hospital
Not yet recruiting --> Active, not recruiting Trial primary completion date: Sep 2015 --> Feb 2016

|||||||||| Trial completion: Tactile Electrosurgical Ablation in Cases of Dysfunctional Uterine Bleeding (clinicaltrials.gov) - Dec 30, 2015
P2, N=106, Completed, Sponsor: Mostafa Hussein
Trial primary completion date: Sep 2015 --> Feb 2016 Recruiting --> Completed

|||||||||| New trial: A Long Term Follow up of Anterior Meshes for Recurrent Prolapse (clinicaltrials.gov) - Dec 30, 2015
P=N/A, N=50, Recruiting, Sponsor: Medway NHS Foundation Trust

|||||||||| New trial: Comparison of the Efficiency of Bipolar Energy Versus Monopolar Energy in Endometrial Ablation in Women Having Menorrhagia (clinicaltrials.gov) - Dec 30, 2015
P=N/A, N=98, Recruiting, Sponsor: Brugmann University Hospital

|||||||||| Enrollment change, Trial termination: Comparison Of The Embryoscope Time-Lapse System With Standard Embryo Culture (clinicaltrials.gov) - Dec 29, 2015
P=N/A, N=31, Terminated, Sponsor: Center for Human Reproduction
Recruiting --> Completed N=120 --> 31 | Recruiting --> Terminated; Equipment was loaned Lifglobal, Guilford, CT, USA and had to be returned.

||||||||||  zoliflodacin (ETX0914) / Entasis Therap, Global Antibiotic Research and Development Partnership
Enrollment closed, Trial primary completion date:  Randomized, Open-label Phase 2 Study of Oral AZD0914 in the Treatment of Gonorrhea (clinicaltrials.gov) -  Dec 29, 2015
P2, N=180, Active, not recruiting,  Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
N=120 --> 31 | Recruiting --> Terminated; Equipment was loaned Lifglobal, Guilford, CT, USA and had to be returned. Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2015 --> Jan 2016

|||||||||| New trial: Validity of Patient-Collected Wet Mounts (clinicaltrials.gov) - Dec 29, 2015
P=N/A, N=40, Recruiting, Sponsor: The University of Texas Health Science Center at San Antonio

||||||||||  Merional (menotropin) / IBSA Institute Biochemical SA, Choriomon (human choriomon gonadotropin (hCG)) / IBSA Institute Biochemical SA, Cetrotide (cetrorelix) / EMD Serono
New trial, Preclinical:  Poor Ovarian Stimulation Response in In Vitro Fertilization (IVF) Program (clinicaltrials.gov) -  Dec 29, 2015
P0, N=216, Completed,  Sponsor: Cairo University

||||||||||  Zybrestat (fosbretabulin) / Oncotelic
New P2/3 trial:  FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer (clinicaltrials.gov) -  Dec 29, 2015
P2/3, N=436, Not yet recruiting,  Sponsor: OXiGENE

|||||||||| Trial completion, Enrollment change, Trial primary completion date: A Trial Evaluating Autologous Endometrial Co-Culture Versus Conventional Medium in the Treatment of Infertility (clinicaltrials.gov) - Dec 25, 2015
P=N/A, N=207, Completed, Sponsor: OVO R & D
Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2015 --> Jan 2016 Recruiting --> Completed | N=1080 --> 207 | Trial primary completion date: Jan 2016 --> Sep 2015

|||||||||| Trial completion: IVF Clinical Trial of Two Different Treatment Protocols. (clinicaltrials.gov) - Dec 25, 2015
P=N/A, N=564, Completed, Sponsor: New Hope Fertility Center
Recruiting --> Completed | N=1080 --> 207 | Trial primary completion date: Jan 2016 --> Sep 2015 Active, not recruiting --> Completed

|||||||||| Phase classification: Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors (clinicaltrials.gov) - Dec 25, 2015
P1, N=15, Completed, Sponsor: Memorial Sloan Kettering Cancer Center
Active, not recruiting --> Completed Phase classification: P=N/A --> P1

||||||||||  RG4733 / Roche
Trial completion, Trial primary completion date, Metastases:  RO4929097 in Treating Patients With Recurrent and/or Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer (clinicaltrials.gov) -  Dec 25, 2015
P2, N=43, Completed,  Sponsor: National Cancer Institute (NCI)
Phase classification: P=N/A --> P1 Terminated --> Completed | Trial primary completion date: Aug 2015 --> Oct 2012

|||||||||| New trial: Morphometrics and Morphokinetics of Thawed Oocytes and Embryos (clinicaltrials.gov) - Dec 25, 2015
P=N/A, N=1272, Completed, Sponsor: Sophie Debrock

|||||||||| Trial completion: STOP: Screening To Obviate Preterm Birth (clinicaltrials.gov) - Dec 23, 2015
P=N/A, N=589, Completed, Sponsor: University of Pennsylvania
Terminated --> Completed | Trial primary completion date: Aug 2015 --> Oct 2012 Recruiting --> Completed

||||||||||  topotecan / Generic mfg., carboplatin / Generic mfg., paclitaxel / Generic mfg.
Trial completion, Metastases:  Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer (clinicaltrials.gov) -  Dec 23, 2015
P3, N=0, Completed,  Sponsor: AGO Study Group
Recruiting --> Completed Active, not recruiting --> Completed

|||||||||| New trial: BlastoTrans: Effects of Blastocyst Stage Compared With Cleavage Stage Embryo Transfer in Women Below 39 Years (clinicaltrials.gov) - Dec 23, 2015
P=N/A, N=388, Recruiting, Sponsor: Istituto Clinico Humanitas

|||||||||| Trial suspension: Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors (clinicaltrials.gov) - Dec 23, 2015
P=N/A, N=75, Suspended, Sponsor: Ohio State University Comprehensive Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Suspended

||||||||||  BNC105 / Bionomics
Enrollment change, Trial withdrawal:  BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients (clinicaltrials.gov) -  Dec 23, 2015
P1/2, N=0, Withdrawn,  Sponsor: Hoosier Cancer Research Network
Active, not recruiting --> Suspended N=134 --> 0 | Completed --> Withdrawn

||||||||||  carboplatin / Generic mfg., paclitaxel / Generic mfg., dasatinib / Generic mfg.
Metastases:  Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer (clinicaltrials.gov) -  Dec 23, 2015
P=N/A, N=18, Active, not recruiting,  Sponsor: National Cancer Institute (NCI)
N=134 --> 0 | Completed --> Withdrawn N=15 --> 18 | Trial primary completion date: Dec 2015 --> Jul 2015

||||||||||  Torisel (temsirolimus) / Pfizer
Trial completion, Enrollment change, Trial primary completion date, Metastases:  Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma (clinicaltrials.gov) -  Dec 23, 2015
P2, N=47, Completed,  Sponsor: AGO Study Group
N=15 --> 18 | Trial primary completion date: Dec 2015 --> Jul 2015 Active, not recruiting --> Completed | N=86 --> 47 | Trial primary completion date: Oct 2014 --> Jun 2015

||||||||||  docetaxel / Generic mfg., gemcitabine / Generic mfg.
Trial primary completion date:  Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus (clinicaltrials.gov) -  Dec 23, 2015
P=N/A, N=25, Completed,  Sponsor: Memorial Sloan Kettering Cancer Center
Active, not recruiting --> Completed | N=86 --> 47 | Trial primary completion date: Oct 2014 --> Jun 2015 Trial primary completion date: Jan 2012 --> Feb 2006

||||||||||  veliparib (ABT-888) / AbbVie
Trial primary completion date, Combination therapy, PARP Biomarker, Metastases:  Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer (clinicaltrials.gov) -  Dec 21, 2015
P1, N=40, Active, not recruiting,  Sponsor: National Cancer Institute (NCI)
Trial primary completion date: Jan 2012 --> Feb 2006 Trial primary completion date: Dec 2015 --> Jun 2016

|||||||||| Trial completion: Endocrine Disrupting Chemicals: Potential Effects on Male and Female Reproductive Health in Saskatchewan (clinicaltrials.gov) - Dec 21, 2015
P=N/A, N=118, Completed, Sponsor: University of Saskatchewan
Trial primary completion date: Dec 2015 --> Jun 2016 Active, not recruiting --> Completed

||||||||||  adavosertib (AZD1775) / AstraZeneca
Enrollment open, Monotherapy, Metastases:  Phase Ib Study to Determine MTD of AZD1775 Monotherapy in Patients With Locally Advanced or Metastatic Solid Tumours. (clinicaltrials.gov) -  Dec 19, 2015
P1, N=18, Recruiting,  Sponsor: AstraZeneca
Active, not recruiting --> Completed Not yet recruiting --> Recruiting

|||||||||| Trial initiation date, Trial primary completion date: Role of Three Dimensional Ultrasound in the Diagnosis of Septate Uterus (clinicaltrials.gov) - Dec 18, 2015
P2, N=38, Completed, Sponsor: Assiut University
Not yet recruiting --> Recruiting Initiation date: Jul 2014 --> Oct 2013 | Trial primary completion date: Aug 2015 --> Jul 2014

|||||||||| New trial: Study on the Antiaging Effect of Chinese Herb Drink (clinicaltrials.gov) - Dec 18, 2015
P=N/A, N=60, Completed, Sponsor: Chung Shan Medical University

|||||||||| New trial: Aspiration of Limited Number of Follicles to Prevent Severe Ovarian Hyperstimulation Syndrome (clinicaltrials.gov) - Dec 18, 2015
P=N/A, N=30, Recruiting, Sponsor: Ahmad Hussieny Salama

||||||||||  Iclusig (ponatinib) / Takeda, Otsuka
Enrollment change, Trial withdrawal:  Ponatinib in the Treatment of FGFR Mutation Positive Recurrent or Persistent Endometrial Carcinoma (clinicaltrials.gov) -  Dec 18, 2015
P=N/A, N=0, Withdrawn,  Sponsor: Washington University School of Medicine
Initiation date: Jul 2014 --> Oct 2013 | Trial primary completion date: Aug 2015 --> Jul 2014 N=15 --> 0 | Not yet recruiting --> Withdrawn

|||||||||| Trial completion: Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO) (clinicaltrials.gov) - Dec 18, 2015
P3, N=8, Completed, Sponsor: King Faisal Specialist Hospital & Research Center
N=15 --> 0 | Not yet recruiting --> Withdrawn Active, not recruiting --> Completed

|||||||||| Enrollment closed, Head-to-Head: GYNOCANS: Study of the Efficacy and Tolerance of Intra-vaginal Treatment With a Total Freeze-dried Culture of Lcr Regenerans® in the Prevention of Relapses of Recurrent Vulvovaginal Candidiasis (clinicaltrials.gov) - Dec 17, 2015
P3, N=322, Active, not recruiting, Sponsor: Probionov
Active, not recruiting --> Completed Recruiting --> Active, not recruiting

|||||||||| Enrollment closed, Enrollment change, Trial primary completion date, HEOR: Survivorship Care Planning in Improving Quality of Life in Survivors of Ovarian Cancer (clinicaltrials.gov) - Dec 16, 2015
P=N/A, N=14, Active, not recruiting, Sponsor: City of Hope Medical Center
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | N=20 --> 14 | Trial primary completion date: Feb 2016 --> Feb 2017

|||||||||| Trial completion: PapU-APV: Research for Papillomavirus as the Examination of Orientation in the Organized Screening of the Cervical Cancer (clinicaltrials.gov) - Dec 16, 2015
P=N/A, N=460, Completed, Sponsor: University Hospital, Brest
Recruiting --> Active, not recruiting | N=20 --> 14 | Trial primary completion date: Feb 2016 --> Feb 2017 Recruiting --> Completed

||||||||||  metformin / Generic mfg.
Trial primary completion date:  Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer (clinicaltrials.gov) -  Dec 15, 2015
P=N/A, N=30, Active, not recruiting,  Sponsor: M.D. Anderson Cancer Center
Recruiting --> Completed Trial primary completion date: Sep 2016 --> Sep 2017

||||||||||  maveropepimut-S (MVP-S) / BioVaxys
Enrollment change, Metastases:  Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer (clinicaltrials.gov) -  Dec 15, 2015
P1/2, N=19, Active, not recruiting,  Sponsor: ImmunoVaccine Technologies, Inc.
Trial primary completion date: Sep 2016 --> Sep 2017 N=15 --> 19

||||||||||  DPX-0907 / BioVaxys
Trial completion, Metastases:  A Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate Cancer (clinicaltrials.gov) -  Dec 15, 2015
P1, N=23, Completed,  Sponsor: ImmunoVaccine Technologies, Inc.
N=15 --> 19 Active, not recruiting --> Completed



	Diseases Companies Products Productz Mechanisms of Action Sites